TREA

98196234 - XARMAPSII

Follow

Information

  • Trademark
  • 98196234
  • Serial Number
    98196234
  • Filing Date
    September 25, 2023
    a year ago
  • Transaction Date
    December 24, 2024
    a day ago
  • Status Date
    December 24, 2024
    a day ago
  • Published for Opposition Date
    November 12, 2024
    a month ago
  • Location Date
    December 24, 2024
    a day ago
  • Status Code
    688
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    LEASER, ANDREW
  • Attorney Docket Number
    1959.23
    Attorney Name
    William R. Samuels
    Law Office Assigned Location Code
    M80
  • Owners
Information
Mark Drawing Code
4
Mark Identification
XARMAPSII
Case File Statements
  • GS0051: Biological preparations for medical use in the treatment of genetic diseases and disorders, and central nervous system (CNS) disorders, namely, neurodegenerative disorders; pharmaceutical preparations, namely, recombinant adeno-associated viral (rAAV) vectors for use in gene therapy; Pharmaceutical preparations for the treatment of genetic diseases and disorders and central nervous system (CNS) disorders, namely, neurodegenerative disorders; Pharmaceutical preparations for use in gene therapy; Clinical medical reagents for use in gene therapy; Pharmaceutical preparations for the treatment of genetic disorders and neurodegenerative disorders; Therapeutic pharmaceutical compositions that include recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy; Pharmaceutical preparations containing adeno-associated viral (AAV) vectors and nucleic acids for a system delivering genes to biological cells for use in the treatment of diseases, sicknesses, and disorders, namely, lysosomal storage disorders; gene therapy preparation for medical use containing genetic materials for sustained protein expression, namely, lysosomal enzyme expression
Case File Event Statements
  • 9/28/2023 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 10/10/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/10/2024 - 8 months ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/17/2024 - 8 months ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/17/2024 - 8 months ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 4/17/2024 - 8 months ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/10/2024 - 5 months ago
    8 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 7/10/2024 - 5 months ago
    7 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 7/24/2024 - 5 months ago
    10 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX
  • 7/24/2024 - 5 months ago
    9 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 7/26/2024 - 5 months ago
    11 - ATTORNEY REVIEW COMPLETED Type: ATRV
  • 10/3/2024 - 2 months ago
    15 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 10/3/2024 - 2 months ago
    13 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 10/3/2024 - 2 months ago
    12 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 10/3/2024 - 2 months ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/3/2024 - 2 months ago
    14 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 10/23/2024 - 2 months ago
    17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 11/12/2024 - a month ago
    18 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/12/2024 - a month ago
    19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 12/12/2024 - 13 days ago
    22 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 12/12/2024 - 13 days ago
    20 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 12/12/2024 - 13 days ago
    21 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 12/24/2024 - a day ago
    23 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM